Normal bone marrow hematopoietic stem cell reserves and normal stromal cell function support the use of autologous stem cell transplantation in patients with multiple sclerosis

Bone Marrow Transplantation

Volumn 36, Issue 12, 2005, Pages 1053-1063

  Papadaki, H A ^a,c   Tsagournisakis, M ^a   Mastorodemos, V ^a   Pontikoglou, C ^a   Damianaki, A ^a   Pyrovolaki, K ^a   Stamatopoulos, K ^b   Fassas, A ^b   Plaitakis, A ^a   Eliopoulos, G D ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b G PAPANICOLAOU HOSPITAL   (Greece)

^c UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Autoimmune diseases; Autologous stem cell transplantation; Multiple sclerosis; Stem cells; T cells

Indexed keywords

BETA1A INTERFERON; CD3 ANTIGEN; CD34 ANTIGEN; CD38 ANTIGEN; FIBRINOGEN; FLT3 LIGAND; HLA DR ANTIGEN; INTERFERON BETA SERINE; MEPREDNISONE; STEM CELL FACTOR;

ADULT; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; BLOOD CELL COUNT; BONE MARROW CULTURE; CELL FRACTIONATION; CELL FUNCTION; CLINICAL ARTICLE; CLONOGENESIS; CLONOGENIC ASSAY; COLONY FORMING CELL; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOMAGNETIC SEPARATION; INHIBITION KINETICS; MALE; MONONUCLEAR CELL; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; STROMA CELL; SUPERNATANT; T LYMPHOCYTE ACTIVATION;

ADULT; ANTIGENS, CD3; ANTIGENS, CD34; ANTIGENS, CD38; AUTOIMMUNE DISEASES; BONE MARROW CELLS; CELLS, CULTURED; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELLS; HEMATOPOIETIC SYSTEM; HLA-DR ANTIGENS; HUMANS; IMMUNOMAGNETIC SEPARATION; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTES; MALE; MIDDLE AGED; MODELS, STATISTICAL; MULTIPLE SCLEROSIS; STEM CELL TRANSPLANTATION; STEM CELLS; STROMAL CELLS; T-LYMPHOCYTES; TIME FACTORS;

EID: 30544432157     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705179     Document Type: Article

References (42)

1. Marmont AM. Stem cell transplantation for severe autoimmune diseases: progress and problems. Haematologica 1998; 83: 733-743.
2. Ikehara S. Bone marrow transplantation for autoimmune diseases. Acta Haematol 1998; 99: 116-132.
3. Burt RK, Traynor A. Hematopoietic stem cell therapy of autoimmune diseases. Curr Opin Hematol 1998; 5: 472-477.
4. Burt RK, Marmont AM. Stem Cell Therapy for Autoimmune Disease. Landes Bioscience: Georgetown, TX, USA.
5. Tyndall A, Koike T. High-dose immunoablative therapy with hematopoietic stem cell support in the treatment of severe autoimmune disease: Current status and future direction. Intern Med 2002; 41: 608-612.
6. Guillaume T, Rubinstein DB, Symann M. Immune reconstitution and immunotherapy after autologous hematopoietic stem cell transplantation. Blood 1998; 92: 1471-1490.
7. Papadaki HA, Kritikos HD, Gemetzi C et al. Bone marrow progenitor cell reserve and function and stromal cell function are defective in rheumatoid arthritis: Evidence for a tumor necrosis factor alpha-mediated effect. Blood 2002; 99: 1610-1619.
8. Papadaki HA, Kritikos HD, Valatas V et al. Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: Improvement following anti-tumor necrosis factor-alpha antibody therapy. Blood 2002; 100: 474-482.
9. + cells and impaired function of bone marrow stromal cells in patients with systemic lupus erythematosus. Br J Haematol 2001; 115: 167-174.
10. Otsuka T, Okamura S, Harada M et al. Multipotent hemopoietic progenitor cells in patients with systemic lupus erythematosus. J Rheumatol 1998; 15: 1085-1090.
11. Snowden JA, Nink V, Cooley M et al. Composition and function of peripheral blood stem and progenitor cell harvests from patients with severe active rheumatoid arthritis. Br J Haematol 1998; 103: 601-609.
12. Burt RK, Fassas A, Snowden J et al. Collection of hematopoietic stem cells from patients with autoimmune diseases. Bone Marrow Transplant 2001; 28: 1-12.
13. Shaughnessy PJ, Ririe DW, Ornstein DL et al. Graft failure in a patient with systemic lupus erythematosus (SLE) treated with high-dose immunosuppression and autologous stem cell rescue. Bone Marrow Transplant 2001; 27: 221-224.
14. Papadaki HA, Gibson FM, Rizzo S et al. Assessment of bone marrow stem cell reserve and function and stromal cell function in patients with autoimmune cytopenias. Blood 2000; 96: 3272-3275.
15. Zhou D, Hemmer B. Specificity and degeneracy: T cell recognition in CNS autoimmunity. Mol Immunol 2004; 40: 1057-1061.
16. Hafler DA. Multiple sclerosis. J Clin Invest 2004; 113: 788-794.
17. van Bekkum DW. Stem cell transplantation in experimental models of autoimmune disease. J Clin Immunol 2000; 20: 10-16.
18. Burt RK, Burns W, Hess A. Bone marrow transplantation for multiple sclerosis. Bone Marrow Transplant 1995; 16: 1-6.
19. Fassas A, Anagnostopoulos A, Kazis A et al. Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot study. Bone Marrow Transplant 1997; 20: 631-638.
20. Fassas A, Anagnostopoulos A, Kazis A et al. Autologous stem cell transplantation in progressive multiple sclerosis -an interim analysis of efficacy. J Clin Immunol 2000; 20: 24-30.
21. Fassas A, Kimiskidis VK. Stem cell transplantation for multiple sclerosis: What is the evidence? Blood Rev 2003; 17: 233-240.
22. McDonald WI, Compston A, Edan G et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-127.
23. Thompson AJ, Montalban X, Barkhof F et al. Diagnostic criteria for primary progressive multiple sclerosis: A position paper. Ann Neurol 2000; 47: 831-835.
24. Papadaki HA, Stamatopoulos K, Damianaki A et al. Activated T-lymphocytes with myelosuppressive properties in patients with chronic idiopathic neutropenia. Br J Haematol 2005; 128: 863-876.
25. Coutinho LH, Gilleece MH, De Wynter EA et al. Clonal and long-term cultures using human bone marrow. In: Testa NG, Molineux G (eds). Haemopoiesis. A Practical Approach. Oxford University Press: Oxford, 1993, pp 75-106.
26. Maciejewski J, Selleri C, Anderson S, Young NS. Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoiesic suppression in vitro. Blood 1995; 85: 3183-3190.
27. + cells of patients with aplastic anaemia. Br J Haematol 1995; 91: 245-252.
28. Zoumbos NC, Djeu JY, Young NS. Interferon is the suppressor of hematopoiesis generated by stimulated lymphocytes in vitro. J Immunol 1984; 133: 769-774.
29. Lapidot T, Petit I. Current understanding of stem cell mobilization: The roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells. Exp Hematol 2002; 30: 973-981.
30. Kojima S, Matsuyama T, Kodera Y. Plasma levels and production of soluble stem cell factor by marrow stromal cells in patients with aplastic anaemia. Br J Haematol 1997; 99: 440-446.
31. Pfister O, Chklovskaia E, Jansen W et al. Chronic overexpression of membrane-bound flt3 ligand by T-lymphocytes in severe aplastic anaemia. Br J Haematol 2000; 109: 211-220.
32. Fassas A, Kimiskidis VK. Autologous hemopoietic stem cell transplantation in the treatment of multiple sclerosis: Rationale and clinical experience. J Neurol Sci 2004; 223: 53-58.
33. Fassas A, Nash RA. Multiple Sclerosis. Bailliere's Clin Haematol 2004; 17: 247-262.
34. Burt RK, Cohen BA, Russell E et al. Hematopoietic stem cell transplantation for progressive multiple sclerosis: Failure of a total body irradiation-based conditioning regimen to prevent disease progression in patients with high disability scores. Blood 2003; 102: 2373-2378.
35. Papadaki HA. Autoreactive T-lymphocytes are implicated in the pathogenesis of bone marrow failure in patients with systemic lupus erythematosus. Leuk Lymphoma 2003; 44: 1301-1307.
36. Khoury SJ, Guttmann CR, Orav EJ et al. Changes in activated T cells in the blood correlate with disease activity in multiple sclerosis. Arch Neurol 2000; 57: 1183-1189.
37. Bilinska M, Frydecka I, Podemski R et al. Expression of Fas antigen on T cell subpopulations in peripheral blood of patients with relapsing-remitting multiple sclerosis. Med Sci Monitor 2001; 7: 251-255.
38. Jensen J, Krakauer M, Sellebjerg F. Increased T cell expression of CD154 (CD40-ligand) in multiple sclerosis. Eur J Neurol 2001; 8: 321-328.
39. + selected autologous peripheral blood stem cell transplantation for multiple sclerosis: Report of toxicity and treatment results at one year of follow-up in 15 patients. Haematologica 2003; 88: 306-314.
40. Rinehart J, Keville L, Clayton S, Figueroa JA. Corticosteroids alter hematopoiesis in vitro by enhancing human monocyte secretion of granulocyte colony-stimulating factor. Exp Hematol 1997; 25: 405-412.
41. + cord blood and bone marrow cells. Ann Hematol 2000; 79: 59-65.
42. Heinrich MC, Dooley DC, Freed AC et al. Constitutive expression of Steel factor gene by human stromal cells. Blood 1993; 82: 771-783.